Form 4: Anixa Biosciences Director Lewis H. Titterton Jr. Acquires Additional Shares
SEC Form 4 Filing
Director Lewis H. Titterton Jr. of Anixa Biosciences Inc. purchased 10,738 shares of common stock at $2.52 per share on June 7, 2024.
Summary
- On June 7, 2024, Lewis H. Titterton Jr., a director of Anixa Biosciences Inc., acquired 10,738 shares of the company's common stock.
- The purchase price was $2.52 per share.
- Following this transaction, Titterton's direct ownership in Anixa Biosciences Inc. amounts to 848,775 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying can be seen as a positive signal, but it's a single transaction and doesn't provide a comprehensive view of the company's health.
Positives
- The director's purchase could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into a company's prospects, although they don't guarantee future performance.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: Lewis H. Titterton Jr. purchased 10,738 shares of Anixa Biosciences Inc. |
| 06/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.